Brenntag SE
Brenntag SE engages in the distribution of chemicals and ingredients in Germany, the United States, the United Kingdom, China, Canada, Italy, Poland, France, and internationally. It operates in two segments, Brenntag Essentials and Brenntag Specialties. The company provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as app… Read more
Brenntag SE (BNR) - Total Liabilities
Latest total liabilities as of September 2025: €6.34 Billion EUR
Based on the latest financial reports, Brenntag SE (BNR) has total liabilities worth €6.34 Billion EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Brenntag SE - Total Liabilities Trend (2013–2024)
This chart illustrates how Brenntag SE's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Brenntag SE Competitors by Total Liabilities
The table below lists competitors of Brenntag SE ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
The Hershey Company
SA:HSHY34
|
Brazil | R$9.10 Billion |
|
Lincoln National Corporation
NYSE:LNC
|
USA | $404.82 Billion |
|
Aier Eye Hospital Group
SHE:300015
|
China | CN¥12.01 Billion |
|
OneMain Holdings Inc
NYSE:OMF
|
USA | $23.99 Billion |
|
Paycom Software, Inc.
NYSE:PAYC
|
USA | $5.87 Billion |
|
Meiji Holdings Co. Ltd
F:3M0
|
Germany | €440.05 Billion |
|
Zhejiang Satellite Petrochemical Co Ltd
SHE:002648
|
China | CN¥37.66 Billion |
|
Krystal Biotech Inc
NASDAQ:KRYS
|
USA | $102.22 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Brenntag SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Brenntag SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Brenntag SE (2013–2024)
The table below shows the annual total liabilities of Brenntag SE from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €6.91 Billion | +15.46% |
| 2023-12-31 | €5.98 Billion | -8.97% |
| 2022-12-31 | €6.57 Billion | +5.97% |
| 2021-12-31 | €6.20 Billion | +36.81% |
| 2020-12-31 | €4.53 Billion | -9.09% |
| 2019-12-31 | €4.99 Billion | +13.47% |
| 2018-12-31 | €4.39 Billion | +2.19% |
| 2017-12-31 | €4.30 Billion | -0.66% |
| 2016-12-31 | €4.33 Billion | +0.98% |
| 2015-12-31 | €4.29 Billion | +11.08% |
| 2014-12-31 | €3.86 Billion | +9.18% |
| 2013-12-31 | €3.53 Billion | -- |